Recent studies found that SIRPG could become a potential biomarker for endometrial carcinoma and head and neck squamous cell carcinoma (43, 44) and might promote the immune escape of tumor cells in lung cancer (45). This evidence concerns the gene SIRPG and endometrial carcinoma.